News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Is Coterra Energy Inc. (CTRA) One of the High-Growth, Low P/E Stocks to Buy Now?
Finviz·2026/02/15 09:12
Qitmeer Network and Imperium Labs Forge Strategic Alliance to Drive Next-Gen DeFi Infrastructure
BlockchainReporter·2026/02/15 09:00
Solana Funding Rates Hit 17-Day Negative Streak — What This Means For Price
Newsbtc·2026/02/15 08:51
Solana (SOL) Founder Anatoly Yakovenko’s Wealth Revealed! What is His Total Wealth? How Many SOL Does He Own?
BitcoinSistemi·2026/02/15 08:45
Canaccord Analyst Initiates Coverage on Tilray Brands, Inc. (TLRY)
Finviz·2026/02/15 08:42
Canaccord is Bullish on Aurora Cannabis Inc. (ACB)
Finviz·2026/02/15 08:30
Alliance Global Keeps a Neutral Rating on Canopy Growth Corporation (CGC)
Finviz·2026/02/15 08:27
Is Advanced Flower Capital Inc. (AFCG) one of the Best Cannabis Stocks to Invest In Now?
Finviz·2026/02/15 08:24
Bitget Launches GetAgent Web for Smarter Crypto Trading
BlockchainReporter·2026/02/15 08:00
MOODENG Rockets 16%—Will Bulls Break Through $0.06?
Cryptonewsland·2026/02/15 07:42
Flash
11:57
Wedbush: The AI market is in the third year of a decade-long building cycleGelonghui, February 17th｜Wedbush: The artificial intelligence market is currently in the third year of a decade-long construction cycle. The recent pullback in technology stocks has been excessive, and the AI investment cycle is still in its early stages.
11:55
Stake completes $31 million Series B funding round, led by National Bank of the UAEPANews reported on February 17 that digital asset real estate investment platform Stake has raised $31 million in a Series B funding round. The round was led by Emirates NBD, with participation from Mubadala Investment Company, Middle East Venture Partners (MEVP), Property Finder, STC NICE, Wa'ed Ventures, GFH Partners, and Ellington Properties. The funds will be used to invest in artificial intelligence, tokenization, and new product development. The company's total seed round funding was $5 million; pre-Series A funding totaled $8 million; Series A funding totaled $14 million; and the current Series B round has raised $31 million, bringing the total to $58 million.
11:44
COMPASS Pathways plc (ticker: CMPS) recently announced that its innovative therapy Comp360 psilocybin for treatment-resistant depression has successfully achieved the primary endpoint in the second pivotal Phase 3 clinical trial.This groundbreaking development marks a solid step forward in validating the safety and efficacy of this therapy, bringing new hope to millions of patients worldwide suffering from treatment-resistant depression.